FN1 and neoplasm: Thrombin has a protease-activated receptor (PAR-1) binding site on tumor cells [288], activating them to bind more tightly to fibronectin, platelets, vWF and endothelial cells, and endowing them with a greater metastatic potential to the lungs in experimental models [289,290].